Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-18-057716
Filing Date
2018-11-07
Accepted
2018-11-06 19:30:59
Documents
1
Group Members
PETER KOLCHINSKY

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv506542_sc13da.htm SC 13D/A 35928
  Complete submission text file 0001144204-18-057716.txt   37411
Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Subject) CIK: 0001399529 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87866 | Film No.: 181164408
SIC: 2834 Pharmaceutical Preparations